Emkay Global Financial Services has come out with its report on pharma space. According to the research firm one can buy Glenmark and IPCA.
Last year, Indian Pharma industry grew by 16%, one of the highest growth rates in the world Pharma market. In the first two quarters Indian Pharma market growth has slowed down to 13% from 16% in 2010. Domestic Indian companies are the ones which are impacted most by this slowdown in growth. In our report, "Domestic Pharma market", we have diagnose the challenges faced by the Indian Pharma market, which was valued at USD 12 billion in 2010 and tried to answer the following questions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
